Latest Lead News

BluGlass Limited has become an approved supplier to the Indian Ministry of Defence, landing its first $230,000 order for gallium nitride laser development from a leading Indian research lab.

Tivan Limited has extended Executive Chairman Grant Wilson’s term by three years, accompanied by a salary increase and proposed performance rights designed to align his incentives with shareholder value as the company advances its Speewah Fluorite Project.

EBR Systems has completed the first commercial US implants of its FDA-approved WiSE wireless cardiac resynchronization therapy system, marking a pivotal step toward broader market adoption and reimbursement.

Kincora Copper has broadened its drilling program in NSW’s Northern Junee-Narromine Belt, advancing exploration with AngloGold Ashanti and uncovering promising signs of porphyry copper and epithermal gold mineralization.

Battery Age Minerals has initiated a comprehensive tailings sampling campaign at its Bleiberg-Hochobir project in Austria to assess germanium concentrations, aiming to secure a critical semiconductor material amid global supply constraints.

Develop Global has commenced concentrate production and cashflow at its Woodlawn copper/zinc mine, marking a significant milestone in its strategy to become a leading ASX copper and base metals company.

Mirrabooka Investment Limited has successfully closed its $85 million entitlement offer, which was oversubscribed, prompting a scale back of Top-Up Facility applications.

Eagle Mountain Mining announces the resignation of its founding Managing Director Charlie Bass, marking a significant leadership transition as new directors join the board.

Apiam Animal Health announces the departure of CEO Chris Richards after nine years, appointing Bruce Dixon as interim managing director during the search for a permanent replacement.

Clarity Pharmaceuticals reports that its Cu-SARTATE diagnostic agent significantly outperforms the current standard in detecting neuroendocrine tumours, paving the way for a pivotal Phase III study.

Lanthanein Resources is set to raise $2.4 million through a placement and a fully underwritten rights issue, while proposing a strategic name change and share consolidation to streamline its capital structure.

Proteomics International has published clinical validation results for PromarkerEso, a novel blood test that detects esophageal adenocarcinoma with remarkable accuracy, promising a non-invasive alternative to costly and uncomfortable endoscopy procedures.